ChemotherapyFDA-approvedFirst-line
Gemcitabine + nab-paclitaxel
Generic name: gemcitabine, nab-paclitaxel
How it works
Gemcitabine and nab-paclitaxel work together to kill cancer cells.
Cancer types
Pancreatic Cancer— All patients
Efficacy
In clinical trials, the combination of gemcitabine and nab-paclitaxel improved overall survival in patients with pancreatic cancer, with a median overall survival of approximately 8.5 months.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.